Literature DB >> 3019875

A rat model of purine nucleoside phosphorylase deficiency.

W R Osborne, R W Barton.   

Abstract

Purine nucleoside phosphorylase (NP; EC 2.4.2.1) deficiency is associated with selective T-cell dysfunction and normal B-cell immunity. In order to create an in vivo model of this immune deficiency, we administered 8-aminoguanosine to rats. This water-soluble nucleoside was rapidly converted by NP to the more potent inhibitor 8-aminoguanine, which has a Ki of 0.19 microM. The accumulation of inosine in plasma showed that administration of 8-aminoguanosine was effectively inhibiting NP activity. The administration of 8-aminoguanosine with deoxyguanosine produced increased levels of dGTP only in thymus cells, and increased levels of GTP in cells from thymus, spleen and lymph node and in red cells. This correlated with assays of deoxyguanosine kinase, which showed significantly higher activity in thymus cells than in cells from spleen and lymph node. The intraperitoneal injection of 8-aminoguanosine alone or with deoxyguanosine for 8 consecutive days caused significant decreases in the number of thymus cells (P less than 0.001) and in lymph node and spleen lymphocytes (P less than 0.01). These data showed that the administration of 8-aminoguanosine to rats provided an animal model of NP deficiency that will allow studies of the specific regulation of T-cell function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019875      PMCID: PMC1453139     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Deoxycytidine kinase from calf thymus. Substrate and inhibitor specificity.

Authors:  T A Krenitsky; J V Tuttle; G W Koszalka; I S Chen; L M Beacham; J L Rideout; G B Elion
Journal:  J Biol Chem       Date:  1976-07-10       Impact factor: 5.157

2.  Deoxycytidine kinase. II. Purification and general properties of the calf thymus enzyme.

Authors:  J P Durham; D H Ives
Journal:  J Biol Chem       Date:  1970-05-10       Impact factor: 5.157

3.  A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts.

Authors:  C Garrett; D V Santi
Journal:  Anal Biochem       Date:  1979-11-01       Impact factor: 3.365

4.  Changes in nucleotide concentrations in the erythrocytes of man, rabbit and rat during short-term storage.

Authors:  B M Dean; D Perrett; M Sensi
Journal:  Biochem Biophys Res Commun       Date:  1978-01-13       Impact factor: 3.575

5.  Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.

Authors:  A Cohen; L J Gudas; A J Ammann; G E Staal; D W Martin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

6.  Purine nucleoside phosphorylase deficiency. Evidence for molecular heterogeneity in two families with enzyme-deficient members.

Authors:  W R Osborne; S H Chen; E R Giblett; W D Biggar; A A Ammann; C R Scott
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

7.  Inhibition of suppressor T-cell development following deoxyguanosine administration.

Authors:  H M Dosch; A Mansour; A Cohen; A Shore; E W Gelfand
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

8.  Use of the integrated steady state rate equation to investigate product inhibition of human red cell adenosine deaminase and its relevance to immune dysfunction.

Authors:  W R Osborne; S H Chen; C R Scott
Journal:  J Biol Chem       Date:  1978-01-25       Impact factor: 5.157

9.  PURINE NUCLEOSIDES. IX. THE SYNTHESIS OF 9-BETA-D-RIBOFURANOSYL URIC ACID AND OTHER RELATED 8-SUBSTITUTED PURINE RIBONUCLEOSIDES.

Authors:  R E HOLMES; R K ROBINS
Journal:  J Am Chem Soc       Date:  1965-04-20       Impact factor: 15.419

10.  Human red cell purine nucleoside phosphorylase. Purification by biospecific affinity chromatography and physical properties.

Authors:  W R Osborne
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

View more
  7 in total

1.  Point mutations at the purine nucleoside phosphorylase locus impair thymocyte differentiation in the mouse.

Authors:  F F Snyder; J P Jenuth; E R Mably; R K Mangat
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

2.  8-Aminoguanosine Exerts Diuretic, Natriuretic, and Glucosuric Activity via Conversion to 8-Aminoguanine, Yet Has Direct Antikaliuretic Effects.

Authors:  Edwin K Jackson; Zaichuan Mi
Journal:  J Pharmacol Exp Ther       Date:  2017-09-19       Impact factor: 4.030

Review 3.  Purine nucleoside phosphorylase as a target to treat age-associated lower urinary tract dysfunction.

Authors:  Lori A Birder; Edwin K Jackson
Journal:  Nat Rev Urol       Date:  2022-09-07       Impact factor: 16.430

4.  8-Aminoguanosine and 8-Aminoguanine Exert Diuretic, Natriuretic, Glucosuric, and Antihypertensive Activity.

Authors:  Edwin K Jackson; Delbert G Gillespie; Zaichuan Mi
Journal:  J Pharmacol Exp Ther       Date:  2016-09-27       Impact factor: 4.030

5.  Design of vectors for efficient expression of human purine nucleoside phosphorylase in skin fibroblasts from enzyme-deficient humans.

Authors:  W R Osborne; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  Suppressed renoprotective purines in COVID-19 patients with acute kidney injury.

Authors:  Edwin K Jackson; Georgios D Kitsios; Michael Y Lu; Caitlin M Schaefer; Cathy J Kessinger; Bryan J McVerry; Alison Morris; Bernard J C Macatangay
Journal:  Sci Rep       Date:  2022-10-17       Impact factor: 4.996

7.  8-Aminoguanine Induces Diuresis, Natriuresis, and Glucosuria by Inhibiting Purine Nucleoside Phosphorylase and Reduces Potassium Excretion by Inhibiting Rac1.

Authors:  Edwin K Jackson; Zaichuan Mi; Thomas R Kleyman; Dongmei Cheng
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.